PDCD1 and neoplasm: This process of tumour-associated immune activation is marked by an increase in T cells and regulatory T cells expressing immune checkpoints—such as programmed cell death protein 1 (PD-1)—which have been associated with more aggressive disease phenotypes, including extranodal invasion.